Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:1130-1136
Published online before print November 3, 2003, doi: 10.1161/01.HYP.0000101691.12358.26
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
42/6/1130    most recent
01.HYP.0000101691.12358.26v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hui, A. S.
Right arrow Articles by Czyzyk-Krzeska, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hui, A. S.
Right arrow Articles by Czyzyk-Krzeska, M. F.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2003;42:1130.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Regulation of Catecholamines by Sustained and Intermittent Hypoxia in Neuroendocrine Cells and Sympathetic Neurons

Anna S. Hui; Justin B. Striet; Gary Gudelsky; Galia K. Soukhova; Evelyne Gozal; Dana Beitner-Johnson; Shang-Z. Guo; Leroy R. Sachleben, Jr; John W. Haycock; David Gozal; Maria F. Czyzyk-Krzeska

From the Departments of Genome Science (A.S.H., J.B.S., D.B.-J., M.F.C.-K.), and Molecular and Cellular Physiology (D.B.-J., M.F.C.-K.), College of Medicine, College of Pharmacy (G.G.), University of Cincinnati, Cincinnati, Ohio; Kosair Children’s Hospital Research Institute and Departments of Pediatrics, Pharmacology, and Toxicology (G.K.S., E.G., S.Z.-G., L.R.S., D.G.), University of Louisville, Louisville, Ky; and the Department of Biochemistry and Molecular Biology (J.W.H.), Louisiana State University Health Sciences Center, New Orleans, La.

Correspondence to Maria F. Czyzyk-Krzeska, Department of Genome Science, University of Cincinnati, College of Medicine, 2180 E Galbraith Road, Cincinnati, OH 45267-0505. E-mail Maria.Czyzykkrzeska{at}uc.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Chronic intermittent hypoxia, a characteristic feature of sleep-disordered breathing, induces hypertension through augmented sympathetic nerve activity and requires the presence of functional carotid body arterial chemoreceptors. In contrast, chronic sustained hypoxia does not alter blood pressure. We therefore analyzed the biosynthetic pathways of catecholamines in peripheral nervous system structures involved in the pathogenesis of intermittent hypoxia-induced hypertension, namely, carotid bodies, superior cervical ganglia, and adrenal glands. Rats were exposed to either intermittent hypoxia (90 seconds of room air alternating with 90 seconds of 10% O2) or to sustained hypoxia (10% O2) for 1 to 30 days. Dopamine, norepinephrine, epinephrine, dihydroxyphenylacetic acid, and 5-hydroxytyptamine contents were measured by high-performance liquid chromatography. Expression of tyrosine hydroxylase and its phosphorylated forms, dopamine ß-hydroxylase, phenylethanolamine N-methyltransferase, and GTP cyclohydrolase-1 were determined by Western blot analyses. Both sustained and intermittent hypoxia significantly increased dopamine and norepinephrine content in carotid bodies but not in sympathetic ganglia or adrenal glands. In carotid bodies, both types of hypoxia augmented total levels of tyrosine hydroxylase protein and its phosphorylation on serines 19, 31, 40, as well as levels of GTP cyclohydrolase-1. However, the effects of intermittent hypoxia on catecholaminergic pathways were significantly smaller and delayed than those induced by sustained hypoxia. Thus, attenuated induction of catecholaminergic phenotype by intermittent hypoxia in carotid body may play a role in development of hypertension associated with sleep-disordered breathing. The effects of both types of hypoxia on expression of catecholaminergic enzymes in superior cervical neurons and adrenal glands were transient and small.


Key Words: blood pressure • catecholamines • chemoreceptors • sympathetic nervous system • sleep apnea syndromes • oxygen • adrenal gland


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Sleep-disordered breathing (SDB) is a frequent condition that affects {approx}5% of the population and is characterized by repetitive episodes of hypoxemia and hypercapnia, followed by arousal, respiratory recovery, and reoxygenation. Persistent SDB is causally associated with substantial cardiovascular morbidity, the most important being systemic arterial hypertension (for recent comprehensive review, see Fletcher, 20031). The mechanisms involved in the genesis of this hypertension appear to involve several different components including augmented sympathetic nerve activity,1–4 altered function of arterial chemoreceptors,1,5–7 elevated levels of circulating norepinephrine (NE),8–10 decreased vascular responses to nitric oxide,11 increased plasma concentrations of endothelin,12,13 and altered regulation of the renal kallikrein-kallistatin pathway.14 The use of animal model systems in which different components of SDB can be studied individually have revealed that intermittent hypoxia (IH) is the critical stimulus underlying development of increased sympathetic activity and hypertension.15,16 Furthermore, the effect of IH requires the presence of functional arterial chemoreceptors.1,5–7

The O2-sensitive cells (type I) of the carotid bodies (CB) closely monitor O2 tension in the arterial blood and, through release of various neurotransmitters, deliver afferent neural traffic information to the respiratory and cardiovascular networks in the brain stem, thereby triggering hyperventilation and increased sympathetic nerve activity. The predominant neurotransmitters synthesized and released in CB type I cells, in a manner highly correlated with the level and duration of hypoxia, are the catecholamines dopamine (DA)17–19 and NE.19 Both DA and NE regulate CB function through feedback attenuation of hypoxia-activated calcium conductance, inhibiting calcium-activated intracellular signaling pathways and reducing the release of other neurotransmitters.20,21 Both inhibit hypoxia-induced ventilation.22,23

Our laboratory previously demonstrated that in CB type I cells, sustained hypoxia (SH) induces gene expression for tyrosine hydroxylase (TH) (EC 1.14.16.2), the rate-limiting enzyme in catecholamine biosynthesis.24 The hypoxic induction of TH mRNA contributes to increased enzymatic activity of the TH protein, which leads to augmented synthesis and release of DA. Using an O2-sensitive cell line (PC12), which serves as a convenient model system, we found that the increase in TH gene expression during hypoxia is due to augmented TH gene transcription and increased stability of TH mRNA.25 In contrast, hypoxia did not affect expression of the TH gene in sympathetic neurons or adrenal chromaffin cells.24

The enzymatic activity of TH is positively regulated by its phosphorylation.26–29 Four phosphorylation sites have been identified: Ser8, Ser19, Ser31, and Ser40. Phosphorylation of the last three serines is regulated in vivo30 and modulates TH activity. Phosphorylation of Ser40 by protein kinase A (PKA),28,29 calcium/calmodulin-dependent protein kinase II (CaMK II),31 or mitogen-activated protein kinase-activated protein (MAPKAP) kinase-1 or -231 increases TH activity, resulting from the loss of inhibition by catecholamines.32 Phosphorylation of Ser31 by MAP kinases also activates TH33 Ser19 is phosphorylated by CaMKII, and this appears to increase the rate of phosphorylation of Ser40.34 However, little is currently known about the effects of hypoxia on the phosphorylation of TH. Although hypoxia elicits membrane depolarization and increases intracellular calcium in PC12 cells,35 both of which may augment TH phosphorylation, hypoxia also inhibits the activities of some of the TH phosphorylating enzymes such as CaMKII and PKA.36

The essential cofactor for TH activity, (6R)-tetrahydrobiopterin, is synthesized de novo from GTP by GTP cyclohydrolase-1 (GTPCH-1, EC 3.5.4.16), the first and rate-limiting step of this biosynthetic pathway.37 It is currently not known if the expression or activity of this enzyme is subject to regulation by O2.

The present study was undertaken to evaluate possible alterations in the peripheral catecholaminergic system during development of arterial hypertension associated with SDB through the use of the well-characterized rat IH experimental model system.14,38,39 We assessed catecholamine biosynthesis in neuroendocrine cells of CB and adrenal gland (AG) and in sympathetic neurons of superior cervical ganglia (SCG) of rats exposed to IH (which become hypertensive) and of rats exposed to SH (which remain normotensive). We found that both SH and IH increase DA and NE content, TH protein and phosphorylation levels, and GTPCH-1 protein levels in the CBs. However, the magnitude of such changes was markedly smaller during IH as compared with SH. Furthermore, no major changes were observed in catecholamine biosynthesis in sympathetic neurons of the SCG or in AG cells during either SH or IH.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Materials
The following antibodies were used: polyclonal anti-TH (1:10 000) and anti-phenylethanolamine N-methyltransferase (PNMT; 1:5000) from Protos Biotech Corp, monoclonal anti-dopamine ß-hydroxylase (DBH) (1:500) from Pharmingen (BD Biosciences), and anti–TH-Ser40-P (1:5000) from Cell Signaling Technology. Phospho-specific antibodies against TH phosphorylated on Ser31 and Ser19 were as previously described40 and used at a concentration of 0.8 µg/mL in 1% polyvinylpyrrolidone, 0.05% Tween-20. The polyclonal antibody against GTPCH-1 (1:500) was a generous gift from Dr G. Kapatos (Wayne State University, Detroit). Secondary HRP-linked anti-rabbit and anti-mouse immunoglobulins were used.

Animals
Male rats (Sprague Dawley; 175 to 200 g) were exposed to either IH or SH for 1, 3, 7, 14, or 30 days in commercially designed chambers (Oxycycler model A44XO, Biospherix) as described previously.14,38,39 Blood pressure was measured with a telemetry system (Data Sciences International). The transmitters (TA11PA-C40) were implanted at least 7 days before recordings began.

Preparation of Protein Extracts and Immunoblotting
Frozen tissues were homogenized in RIPA buffer (10 mmol/L Tris-HCl, pH 7.5, 300 mmol/L NaCl, 3 mmol/L MgCl2, 0.5% NP40, 0.1% SDS, 0.5% sodium deoxycholate, 0.5 mmol/L PMSF, 10 mmol/L NaF, 10 µg/mL leupeptin, 10 µg/mL aprotinin, 1 µmol/L lactacystin, 2 mmol/L orthovanadate) with a Dounce homogenizer (pestle B) at 4°C. The homogenates were incubated at 4°C for 1 hour with gentle agitation and centrifuged at 15 000 rpm for 20 minutes. The supernatants were further centrifuged at 40 000 rpm for 30 minutes.

Equal amounts of lysates (80 µg of CB extracts and 150 µg of AG or SCG extracts) were denatured by boiling in SDS sample buffer, resolved by SDS-PAGE on 4% to 22% gradient gels, and detected by immunoblotting as previously described.41 The data are presented as percent changes in immunoreactivity in hypoxic samples as compared with the immunoreactivity measured in normoxic samples in the same experiment and on the same blot.

High-Performance Liquid Chromatography Measurements of Catecholamines
Frozen tissues were homogenized in 0.2N perchloric acid and centrifuged at 13 000 rpm for 15 minutes. NE and epinephrine (E) were quantified in a 20-µL sample injected onto a C-18 column (MD-150, ESA, Inc) connected to a LC-4B amperometric detector (Bioanalytical Systems) and a glassy carbon electrode with a potential of +600 mV. DA, dihydroxyphenylacetic acid (DOPAC), 5-hydroxytryptamine (5-HT) were quantified in samples injected onto a C-18 column (MD-150, ESA, Inc) connected to a Coulochem detector (ESA, Inc). The values of amine concentrations were normalized to the protein concentration in the pellets left after perchloric acid extraction, which were resuspended in buffer containing 1:3 ratio of 0.2 mol/L NaOH and RIPA buffer.

Statistical Evaluation of the Data
Data are expressed as mean±SEM. Analysis was performed by GraphPad Instat version 3.0 for Windows, with 1-way ANOVA, followed by Tukey-Kramer multiple comparison tests. Differences having a value of P<0.05 were considered to be statistically significant.

An expanded Methods section can be found in an online supplement available at http://www.hypertensionaha.org.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Blood Pressure
Rats exposed to IH developed significantly higher values of systolic and diastolic blood pressure as compared with animals exposed to room air or SH (Figure 1). The increase in systolic and diastolic blood pressure started within the first week of exposure, and both values were significantly higher (P<0.001) at the end of 30 days of exposure as compared with animals exposed to room air.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. Effects of exposure to sustained or intermittent hypoxia for the indicated number of days on systolic (•) or diastolic ({circ}) blood pressure values. Data are expressed as average blood pressure ±SEM (n=6). At day 30, blood pressure levels were significantly higher in rats exposed to intermittent hypoxia than to sustained hypoxia or room air (***P<0.001).

Carotid Body
Exposure of rats to 10% SH for 14 days increased DA and NE content measured in CBs (Figures 2A and 2B). Equivalent durations of IH increased catecholamine content as well; however, the effects of IH were significantly smaller than those mediated in response to SH (Figure 2). Both types of hypoxia resulted in similar increases in the concentration of the DA metabolite DOPAC (Figure 2C). In contrast to catecholamines, hypoxia did not affect the concentration of another biogenic amine, serotonin (5-HT) (Figure 2D).



View larger version (37K):
[in this window]
[in a new window]
 
Figure 2. Effects of 14 days of sustained (SH) and intermittent (IH) hypoxia on CB DA (A), NE (B), DOPAC (C), and 5-HT (D) levels. Mean±SEM values are shown. *P<0.05, **P<0.01, ***P<0.001 (normoxic samples, n=6; hypoxic samples n=15).

Consistent with the above results, SH strongly increased the levels of TH immunoreactivity, as well as that of phosphorylated TH sites (Figures 3 and 4Down). The increases in total TH protein accumulation and phosphorylations on Ser19, Ser31, Ser40 residues developed rapidly and occurred within the first day of exposure to SH.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 3. Effects of sustained and intermittent hypoxia on tyrosine hydroxylase protein and phosphorylation levels and on DBH protein levels in CBs. Representative Western blots are shown. N indicates normoxia; tTH, total TH.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 4. Quantification of immunoreactivity in CBs from rats exposed to sustained or intermittent hypoxia. Extracts obtained from all CBs (3 sets of 6 to 7 rats per time point in each set) were pooled and analyzed by Western blot; immunoreactivity was quantified by measurement of optical density. Values are expressed as a percentage of those measured in normoxic rats (N).

IH also affected TH protein accumulation and phosphorylation in CBs. However, the increases in TH expression and phosphorylation were not as prominent as those induced by SH (Figures 3 and 4 Up). Furthermore, the increase in TH protein accumulation was delayed during IH and began only after 7 days of exposure, such that the final increase measured at the end of the 30 days’ exposure to IH was 5-fold smaller than that elicited by corresponding exposures to SH (Figures 3 and 4Up). Similarly, phosphorylation of TH protein during IH was less prominent and delayed until days 14 and 30 days of exposure (Figure 3). The effects of SH or IH on DBH levels in the CB were only transient (Figure 3), and no PNMT immunoreactivity was detected in CB extracts (not shown).

Superior Cervical Ganglia and Adrenal Glands
In contrast to the substantial effects of both SH and IH on catecholamine metabolism in CB tissues, no significant changes occurred in the SCGs and AGs. The Table shows measurements of DA, NE, E, DOPAC, and 5-HT contents in sympathetic neurons and adrenal chromaffin cells. The absence of significant differences in catecholamine content was consistent with the absence of major changes in TH protein content or phosphorylation (Figure 5).


View this table:
[in this window]
[in a new window]
 
Effects of SH and IH on Content of Biogenic Amines in CB, SCG, and AG



View larger version (49K):
[in this window]
[in a new window]
 
Figure 5. Effects of sustained and intermittent hypoxia on TH protein and phosphorylation, DBH protein, and PNMT protein levels in extracts from SCGs (A) and AGs (B). Representative Western blots are shown. N indicates normoxia.

The effects of sustained and intermittent hypoxia on immunoreactivity of TH protein and its phosphorylation in SCGs and AGs were small compared with the changes measured in CB, and the differences were not statistically significant (Figure 5). In SCGs, exposure to SH resulted in a decrease in the immunoreactivity for phospho-Ser19 or -Ser40 and DBH and a very small increase in total TH protein and phospho-Ser31 (Figure 5A). Exposure to IH resulted in somewhat stronger inducing effects on the total TH protein and phosphorylation on Ser19 and Ser31. Immunoreactivity of phospho-Ser40 first increased and then decreased. DBH levels showed some level of induction that was transient in SH and more long-lasting in IH (Figure 5A).

In AGs, SH modestly increased TH protein levels, particularly at the later time points, and had no statistically significant effects on the pattern of TH phosphorylation (Figure 5B). Phosphorylation on Ser19 was somewhat increased (not significantly) in response to 30 days of SH, whereas phospho-Ser31 and phospho-Ser40 immunoreactivities were transiently increased around days 3 to 7 and then decreased to control levels by 30 days of hypoxic exposure. IH induced transient increases in TH protein, phospho-Ser31, and phospho-Ser40 levels between days 3 and 7. However, no changes in TH phosphorylation occurred on Ser19 in the AG extracts of rats exposed to IH (Figure 5B). Furthermore, both types of hypoxia induced DBH protein levels, and neither SH or IH had any effect on PNMT protein levels in the AG.

GTP Cyclohydrolase-1
To evaluate the potential role of the tetrahydrobiopterin cofactor in regulation of TH activity by hypoxia, we assessed the effects of hypoxia on GTPCH-1, the rate-limiting enzyme in tetrahydrobiopterin synthesis, in carotid bodies (Figure 6). SH induced significant accumulation of GTPCH-1 protein, beginning at day 1 of exposure and remaining elevated for the entire duration of this stimulus. IH also increased GTPCH-1 protein levels, but this response was delayed, and levels after 14 days of IH were comparable to those induced by 24 hours of SH (Figure 6). Thus, accumulation of GTPCH-1 was not affected in SCGs or AGs after either SH or IH (Figure 6).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 6. Effects of sustained and intermittent hypoxia on protein levels of GTPCH-1 in CBs, SCGs, and AGs. Representative Western blot probed with GTPCH-1 antibodies is shown. N in 12.7dicates normoxia.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Rats without any genetic hypertensive background exposed to our chronic IH protocol14,38,39 had elevated systolic and diastolic blood pressure, thereby confirming previous studies using a variety of intermittent hypoxia protocols.13–16 In this context, we examined markers of the catecholamine biosynthetic pathway in peripheral catecholaminergic tissues directly participating in adaptation to hypoxia and in development of arterial hypertension during SDB. We made several novel observations, providing insights into mechanisms by which hypoxia induces catecholamine biosynthesis in CBs. For the first time, we show that hypoxia induces phosphorylation of TH at serines 19, 31, and 40 in CB cells and also increases GTPCH-1 protein levels in this organ. These results extend previous work from this laboratory24,25,41,42 and demonstrate that the hypoxic induction of TH protein and DA biosynthesis is regulated at multiple steps, including induction of gene expression, posttranslational modifications, and induction of the biosynthesis of the relevant cofactors.

Although IH and SH result in similar levels of low arterial oxygen tension (mean PaO2=40 to 42 mm Hg; D. Gozal, personal communication, 2002), IH produces much smaller increases in DA and NE, TH protein, TH phosphorylation, and GTPCH-1 protein levels. This lesser induction of the catecholaminergic pathway by IH versus SH holds true whether total or absolute durations of exposure (ie, total exposure time or actual time spent in hypoxia, respectively) are considered. Indeed, 30 days of exposure to IH increased TH protein levels and regulated its phosphorylation state to a similar degree as only 1 day of SH. Clearly, however, the absolute hypoxic exposure during 30 days of IH was longer than during 1 day of SH. A possible mechanistic explanation is that IH, alternating episodes of hypoxia and reoxygenation, causes oxidative stress.39 TH expression is induced by hypoxia24,25,41 but is downregulated by oxidative stress.42 At the same time, mechanism(s) responsible for DA turnover appear to be affected similarly by both SH and IH. Indeed, the levels of DOPAC, the DA metabolite generated by monoamine oxidase, are similar in CBs from rats exposed to either SH or IH. The increases in NE concentration in the CB appear to correlate with the levels of DA and thus may simply result from increased amount of substrate for DBH, the expression of which is not altered by hypoxia in the CB. However, an increase in the number of DBH-expressing glomus cells, as proposed by others,43 needs to be considered.

The data provide important insights in understanding the role of CB in development of IH induced hypertension. The smaller induction of catecholamine expression in CB during IH as compared with SH may contribute to the relatively higher sympathetic response during IH. Both DA and NE have attenuating effect on the CB activity and inhibit hypoxia-induced hyperventilation.20–23 Thus, it is likely that the lower amounts of DA and NE released during IH are less attenuating, leading to much a stronger activation of CB input, which is then translated into higher sympathetic activity.

Relatively high levels of NE induced by both types of hypoxia in CB are comparable with the levels measured in SCGs, and thus CB could be a source of elevated blood NE. Such a strong effect of carotid body on plasma catecholamine levels is not unlikely in view of known circulatory effects of biogenic amines released from CB tumors or other small paragangliomas.44,45 Yet, SH stimulates higher amounts of NE synthesized (and released from) by the CB than IH, without any elevation in blood pressure. This finding indicates that IH and SH have different effects on peripheral vascular mechanisms, the former promoting vasoconstriction and the latter promoting vasodilation. This is consistent with impairment of the kallikrein-kallistatin pathway, vasodilation, and vascular hypertrophy in response to IH but not to SH.14

An intriguing observation is that neither SH or IH altered catecholamine content in SCGs or AGs and that the effects on expression of catecholamine synthesizing enzymes were very small. These results differ somewhat from the earlier reports showing an increase in TH protein in AGs from rats exposed to SH for up to 22 days46 and in DA but not NE in SCGs.47 A possible explanation for this discrepancy is that catecholamine contents in these studies were expressed per individual ganglion or gland, the size of which increases with chronic hypoxia, whereas our measurements were normalized to protein content in each tissue. The increases in TH Vmax have been previously reported in sympathetic postganglionic neurons and cells of adrenal medulla (see references in Czyzyk-Krzeska et al, 199224) in response to relatively short-lasting SH. However, we failed to detect any changes in TH total protein levels or its phosphorylation during the first day of exposure to sustained hypoxia in SCGs and measured a weak increase in total TH protein in AG. A potential explanation is that hypoxia causes an early and transient increase in TH enzymatic activity that disappears within 24 hours of exposure, the time frame at which we began our measurements. Interestingly, we observed a small tendency for increase in DBH levels in SCG and AG during IH but not SH. Although this increase in DBH did not correlate with increased NE levels in SCG and AG, the results suggest that perhaps longer exposures to IH would elevate NE in these tissues through augmented DBH activity.

The results also suggest that IH could lead to increased sympathetic activity by inducing molecular changes in the upstream central nervous system neurons without any changes in the neurotransmitter biosynthesis in the peripheral neurons. In accordance with this hypothesis, chronic IH stimulates persistent expression of immediate early genes in the brain stem.48

Perspectives
Hypertension occurring during SDB results from SDB-associated IH and requires activity of arterial chemoreceptors. We have provided initial evidence that attenuation of catecholamine biosynthesis and release in CB during IH as compared with SH may contribute to augmented chemoreceptor input and increased sympathetic output leading to the development of hypertension. In addition, we found limited evidence to support any major effects of IH on catecholaminergic phenotype of AG or SCG.


*    Acknowledgments
 
This work was supported by following grants to M.F.C.-K.: NIH HL58687, HL66312, ACS Research Scholar Grant GMC101430; to D.G.: NIH HL63912 and HL69932; and to J.W.H.: NIH MH00967, and NS25134. We thank Glenn Doerman for preparation of the figures.

Received July 22, 2003; first decision August 13, 2003; accepted October 7, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Fletcher EC. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep. 2003; 1: 15–19.
  2. Fletcher EC, Lesske J, Culman J, Miller CC, Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension. 1992; 20: 612–619.[Abstract/Free Full Text]
  3. Bao G, Mftreveli N, Li R, Taylor A, Fletcher EC. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol. 1997; 83: 95–101.[Abstract/Free Full Text]
  4. Narkiweicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens. 1997; 15: 1613–1619.[CrossRef][Medline] [Order article via Infotrieve]
  5. Fletcher EC, Lesske J, Behm R, Miller CC, Stauss K, Unger T. Carotid body chemoreceptors, systemic blood pressure and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol. 1992; 72: 1978–1984.[Abstract/Free Full Text]
  6. Lesske J, Fletcher EC, Bao G, Unger T. Hypertension caused by chronic intermittent hypoxia: influence of chemoreceptors and sympathetic nervous system. J Hypertens. 1997; 15: 1593–1603.[CrossRef][Medline] [Order article via Infotrieve]
  7. Garcia-Rio F, Racionero MA, Pino JM, Martinez I, Ortuno F, Villasante C, Villamor J. Sleep apnea and hypertension: the role of peripheral chemoreceptors and the sympathetic nervous system. Chest. 2000; 117: 1417–1425.[CrossRef][Medline] [Order article via Infotrieve]
  8. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertensive. Sleep. 1987; 10: 35–44.[Medline] [Order article via Infotrieve]
  9. Marrone O, Riccombo L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest. 1993; 103: 722–727.[CrossRef][Medline] [Order article via Infotrieve]
  10. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J. The effects of sleep apnea on plasma and urinary catecholamines. Sleep. 1995; 18: 377–381.[Medline] [Order article via Infotrieve]
  11. Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Morena H, Hoffman BB, Blaschke TF. Vascular reactivity in obstructive sleep apnea syndrome. Am J Resp Crit Care Med. 2000; 161: 187–191.[Abstract/Free Full Text]
  12. Saarelainen S, Seppala E, Laasonen K, Hasan J. Circulating endothelin-1 in obstructive sleep apnea. Endothelium. 1997; 5: 115–118.[Medline] [Order article via Infotrieve]
  13. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension. 2001; 37: 511–515.[Abstract/Free Full Text]
  14. Thongboonkerd V, Gozal E, Sachleban LR, Arthur JM, Pierce WM, Cai J, Bader M Pesquero JB, Gozal D, Klein JB. Proteomic analysis reveals alterations in renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem. 2002; 277: 34708–34716.[Abstract/Free Full Text]
  15. Van den Aardweg JG, Karemaker JM. Repetitive apneas induce periodic hypertension in normal subjects through hypoxia. J Appl Physiol. 1992; 72: 821–827.[Abstract/Free Full Text]
  16. Fletcher EC, Bao G. The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep. 1996; 19: S210–S212.[Medline] [Order article via Infotrieve]
  17. Fidone S, Gonzalez C, Yoshizaki K. Effects of hypoxia on catecholamine synthesis in rabbit carotid body in vitro. J Physiol. 1982; 333: 81–91.[Abstract/Free Full Text]
  18. Fidone S, Gonzalez C, Yoshizaki K. Effects of low oxygen on the release of dopamine from the rabbit carotid body in vitro. J Physiol. 1982; 333: 93–110.[Abstract/Free Full Text]
  19. Vicario I, Rigual R, Obeso A, Gonzalez C. Characterization of the synthesis and release of catecholamine in the rat carotid body in vitro. Am J Physiol Cell Physiol. 2000; 278: C490–C499.[Abstract/Free Full Text]
  20. Benot AR, Lopez Barneo J. Feedback inhibition of Ca2+ currents by dopamine in glomus cells of the carotid body. Eur J Neurosci. 1990; 2: 809–812.[CrossRef][Medline] [Order article via Infotrieve]
  21. Overholt JL, Prabhakar NR. Norepinephrine inhibits a toxin resistant Ca2+ current in carotid body glomus cells: evidence for a direct G protein mechanism. J Neurophysiol. 1999; 81: 225–233.[Abstract/Free Full Text]
  22. Welsh MJ, Heistad DD, Abboud FM. Depression of ventilation by dopamine in man: evidence for an effect on the chemoreceptor reflex. J Clin Invest. 1978; 61: 708–713.[Medline] [Order article via Infotrieve]
  23. Kou YR, Ernsberger P, Cragg PA, Cherniack N, Prabhakar NR. Role of alpha 2-adrenergic receptors in the carotid body response to isocapnic hypoxia. Brain Res. 1991; 83: 353–364.
  24. Czyzyk-Krzeska MF, Bayliss DA, Lawson EE, Millhorn DE. Regulation of tyrosine hydroxylase gene expression in the rat carotid body by hypoxia. J Neurochem. 1992; 58: 1538–1546.[CrossRef][Medline] [Order article via Infotrieve]
  25. Czyzyk-Krzeska MF, Furnari BA, Lawson EE, Millhorn DE. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J Biol Chem. 1994; 269: 760–764.[Abstract/Free Full Text]
  26. Haycock JW. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31 and 40. J Biol Chem. 1990; 265: 11682–11691.[Abstract/Free Full Text]
  27. Haycock JW. Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser,19 Ser,31 Ser40. Neurochem Res. 1993; 18: 15–26.[CrossRef][Medline] [Order article via Infotrieve]
  28. Campbell DG, Hardie DG, Vulliet PR. Identification of the four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J Biol Chem. 1986; 261: 10489–10492.[Abstract/Free Full Text]
  29. Roskoski R Jr., Roskoski LM. Activation of tyrosine hydroxylase in PC12 cells by cyclic GMP and cyclic AMP second messenger systems. J Neurochem. 1987; 48: 236–242.[CrossRef][Medline] [Order article via Infotrieve]
  30. Haycock JW, Haycock DA. Tyrosine hydroxylase in rat brain dopaminergic nerve terminals: multiple-site phosphorylation in vivo and in synaptosomes. J Biol Chem. 1991; 266: 5650–5657.[Abstract/Free Full Text]
  31. Sutherland C, Alterio J, Campbell DG, LeBourdelles B, Mallet J, Haavik J, Cohen P. Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen activated protein (MAP) kinase and MAP-kinase activated kinases 1 and 2. Eur J Biochem. 1993; 217: 715–722.[Medline] [Order article via Infotrieve]
  32. McCulloch RI, Daubner SC, Fitzpatrick PF. Effects of substitution at serine 40 of tyrosine hydroxylase on catecholamine binding. Biochemistry. 2001; 40: 7273–7278.[Medline] [Order article via Infotrieve]
  33. Haycock JW, Ahn NG, Cobb MH, Krebs EG. ERK1 and ERK2, two microtubule associated protein 2 kinases mediate the phosphorylation of tyrosine hydroxylase at serine 31 in situ. Proc Natl Acad Sci U S A. 1992; 89: 2365–2369.[Abstract/Free Full Text]
  34. Bevilaqua LRM, Graham ME, Dunkley PR, von Nagy-Felsobuki EL, Dickson PW. Phosphorylation of Ser19 alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of Ser40. J Biol Chem. 2001; 276: 40411–40416.[Abstract/Free Full Text]
  35. Zhu WH, Conforti L, Czyzyk-Krzeska MF, Millhorn DE. Membrane depolarization and dopamine secretion in PC12 cells during hypoxia are regulated by an O2-sensitive K+ current. Am J Physiol. 1996; 271: C658–C665.[Medline] [Order article via Infotrieve]
  36. Beitner-Johnson D, Leibold J, Millhorn DE. Hypoxia regulates the cAMP- and Ca2+/calmodulin signaling systems in PC12 cells. Biochem Biophys Res Commun. 1998; 242: 61–6.[CrossRef][Medline] [Order article via Infotrieve]
  37. Thony B, Auerbach G, Blau N. Tetrahydropterin biosynthesis, regeneration and functions. Biochem J. 2000; 347: 1–16.[CrossRef][Medline] [Order article via Infotrieve]
  38. Gozal D, Daniel JM, Dohniach GP. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci. 2001; 21: 2442–2450.[Abstract/Free Full Text]
  39. Row BW, Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med. 2003; 167: 1548–1553.[Abstract/Free Full Text]
  40. Salvatore MF, Garcia Espana A, Goldstein M, Deutch AY, Haycock JW. Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: effects of acute haloperidol and related compounds. J Neurochem. 2000; 75: 225–232.[CrossRef][Medline] [Order article via Infotrieve]
  41. Schnell PO, Ignacak ML, Bauer AL, Striet JB, Paulding WR, Czyzyk-Krzeska MF. Regulation of tyrosine hydroxylase promoter activity by hypoxia-inducible factors and von Hippel-Lindau tumor suppressor protein. J Neurochem. 2003; 85: 483–491.[Medline] [Order article via Infotrieve]
  42. Kroll SL, Czyzyk-Krzeska MF. The role of H2O2 and heme-containing oxygen sensors in O2-dependent regulation of tyrosine hydroxylase gene expression. Am J Physiol. 1998; 274: C167–C174.[Medline] [Order article via Infotrieve]
  43. Verna A, Schamel A, Pequignot J-M. Long-term hypoxia increases the number of norepinephrine-containing glomus cells in the rat carotid body: a correlative immunocytochemical and biochemical study. J Autonom Nerv Syst. 1993; 44: 171–177.[Medline] [Order article via Infotrieve]
  44. Strauss M, Nicholas GG, Abt AB, Harrison TS, Seaton JF. Malignant catecholamine-secreting carotid body paraganglioma. Otolaryngol Head Neck Surg. 1983; 91: 315–321.[Medline] [Order article via Infotrieve]
  45. Newland MC, Hurlbert BJ. Chemodectoma diagnosed by hypertension and tachycardia during anesthesia. Anesth Analg. 1980; 59: 388–390.[Free Full Text]
  46. Schmitt P, Garcia C, Soulier V, Pujol JF, Pequignot JM. Influence of long-term hypoxia on tyrosine hydroxylase in the rat carotid body and adrenal gland. J Autonom Nerv Syst. 1992; 40: 13–20.[CrossRef][Medline] [Order article via Infotrieve]
  47. Peyronnet J, Poncet L, Denoroy L, Pequignot JM, Lagercrantz H, Dalmaz Y. Plasticity in the phenotypic expression of catecholamines and vasoactive intestinal peptide in adult rat superior cervical and stellate ganglia after long-term hypoxia in vivo. Neuroscience. 1999; 91: 1183–1194.[CrossRef][Medline] [Order article via Infotrieve]
  48. Greenberg HE, Sica AL, Scharf SM, Ruggerio DA. Expression of c-fos in the rat brainstem after chronic intermittent hypoxia. Brain Res. 1999; 816: 638–645.[CrossRef][Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. A. Varney and E. H. Schlenker
Thyroid status affects 5-HT2A receptor modulation of breathing before, during, and following exposure of hamsters to acute intermittent hypoxia
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2070 - R2080.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Spaak, Z. J. Egri, T. Kubo, E. Yu, S.-I. Ando, Y. Kaneko, K. Usui, T. D. Bradley, and J. S. Floras
Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea
Hypertension, December 1, 2005; 46(6): 1327 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Klein, M. T. Barati, R. Wu, D. Gozal, L. R. Sachleben Jr., H. Kausar, J. O. Trent, E. Gozal, and M. J. Rane
Akt-mediated Valosin-containing Protein 97 Phosphorylation Regulates Its Association with Ubiquitinated Proteins
J. Biol. Chem., September 9, 2005; 280(36): 31870 - 31881.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. Gozal, Z. A. Shah, J.-M. Pequignot, J. Pequignot, L. R. Sachleben, M. F. Czyzyk-Krzeska, R. C. Li, S.-Z. Guo, and D. Gozal
Tyrosine hydroxylase expression and activity in the rat brain: differential regulation after long-term intermittent or sustained hypoxia
J Appl Physiol, August 1, 2005; 99(2): 642 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E.-K. Pae, J. Wu, D. Nguyen, R. Monti, and R. M. Harper
Geniohyoid muscle properties and myosin heavy chain composition are altered after short-term intermittent hypoxic exposure
J Appl Physiol, March 1, 2005; 98(3): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Gozal, L. R. Sachleben Jr., M. J. Rane, C. Vega, and D. Gozal
Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms
Am J Physiol Cell Physiol, March 1, 2005; 288(3): C535 - C542.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Yuan, J. Nanduri, C. R. Bhasker, G. L. Semenza, and N. R. Prabhakar
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
J. Biol. Chem., February 11, 2005; 280(6): 4321 - 4328.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
42/6/1130    most recent
01.HYP.0000101691.12358.26v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hui, A. S.
Right arrow Articles by Czyzyk-Krzeska, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hui, A. S.
Right arrow Articles by Czyzyk-Krzeska, M. F.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation